Michael Scolaro

Michael Scolaro

Oct 06, 2017

Group 6 Copy 233
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Do Australian bats have what it takes to survive the deadly White Nose Syndrome?

Australian bats are at risk from the deadly fungal disease White Nose Syndrome (WNS), which is expected...

Unlock the Secrets of Animals that Survive Freezing!

The North American wood frog Rana sylvatica can survive being frozen solid - no heartbeat, no brain activity...

The Dogs of Chernobyl Research Initiative

The Chernobyl disaster site has hundreds of feral dogs that are in need of care. A team of students from...

Backer Badge Funded